Apolipoprotein A1 level in plasma of patients with diabetes and diabetic patients with COVID-19 as a possible marker of disease

by Tronko, M.D., Cherviakova, S.A., Pushkarev, V.V., Belchina, Y.B., Kovzun, O.I., Pushkarev, V.M., Sokolova, L.K.
Published 2021

Apolipoprotein B and oxLDL levels in plasma of patients with diabetes, cardiovascular disease, and COVID-19

by Tronko, M.D., Cherviakova, S.A., Pushkarev, V.V., Belchina, Y.B., Kovzun, O.I., Pushkarev, V.M., Sokolova, L.K.
Published 2021

Effects of COVID-19, diabetes mellitus, and cardiovascular diseases on insulin receptor substrate-1 amount in the blood plasma of patients

by Tronko, M.D., Pushkarev, V.V., Sokolova, L.K., Cherviakova, S.A., Belchina, Yu.B., Kovzun, O.I., Pushkarev, V.M.
Published 2021

Effects of COVID-19 and diabetes mellitus on AMPKα1 and IRS-1 amount in the blood plasma of patients

by Tronko, M.D., Pushkarev, V.V., Sokolova, L.K., Cherviakova, S.A., Belchina, Y.B., Kovzun, O.I., Guda, B.B., Pushkarev, V.M.
Published 2022

NT-proBNP blood levels in patients with type 2 diabetes mellitus with anemia and after the dapagliflozin treatment

by Sokolova, L.K., Pushkarev, V.M., Belchina, Yu.B., Pushkarev, V.V., Furmanova, O.V., Cherviakova, S.A., Kovzun, O.I., Tronko, M.D.
Published 2018